Get the Stockscreener App
2.55
0.00%
0.00
After Hours:
2.50
-0.05
-1.96%
Xenetic Biosciences Inc stock is traded at $2.55, with a volume of 44,191.
It is up +0.00% in the last 24 hours and up +22.60% over the past month.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
See More
Previous Close:
$2.55
Open:
$2.67
24h Volume:
44,191
Relative Volume:
0.92
Market Cap:
$5.84M
Revenue:
$2.54M
Net Income/Loss:
$-4.13M
P/E Ratio:
-0.9273
EPS:
-2.75
Net Cash Flow:
$-4.11M
1W Performance:
+2.00%
1M Performance:
+22.60%
6M Performance:
-29.24%
1Y Performance:
-38.55%
1-Day Range:
$2.55
$2.69
1-Week Range:
$2.41
$2.79
52-Week Range:
$1.90
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Name
Xenetic Biosciences Inc
Sector
Industry
Phone
781-778-7720
Address
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.55 | 5.84M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-20 | Initiated | Maxim Group | Buy |
Xenetic Biosciences Inc Stock (XBIO) Latest News
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - caller.com
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - chieftain.com
Earnings Risk: Is Xenetic Biosciences Inc stock a value trapWeekly Trade Summary & Short-Term High Return Strategies - baoquankhu1.vn
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - hattiesburgamerican.com
Merger Talk: Can Xenetic Biosciences Inc maintain sales growthInsider Selling & Weekly Setup with High ROI Potential - baoquankhu1.vn
Aug Opening: Whats next for PGEN stockTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
FOMO Trade: Does Xenetic Biosciences Inc stock reflect fundamentals2025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Take Profit: Will Xenetic Biosciences Inc stock benefit from M A2025 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Activity Recap: Is Xenetic Biosciences Inc stock good for income investorsJuly 2025 Highlights & Daily Price Action Insights - baoquankhu1.vn
Recap Report: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Quarterly Recap: Whats the outlook for Xenetic Biosciences Incs sectorSell Signal & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Analyst Downgrade: Whats the outlook for Xenetic Biosciences Incs sectorTrade Entry Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Is Xenetic Biosciences Inc. on track to beat earningsEarnings Growth Summary & Real-Time Volume Triggers - bollywoodhelpline.com
Published on: 2026-01-14 16:49:08 - baoquankhu1.vn
Can Xenetic Biosciences Inc. stock sustain institutional interestJuly 2025 Levels & Fast Gain Swing Alerts - Улправда
Xenetic Biosciences faces ongoing delays in annual meeting - TipRanks
Xenetic Biosciences Adjourns Annual Meeting Again - TradingView — Track All Markets
Is Xenetic Biosciences Inc. (3XB0) stock safe for risk averse investorsQuarterly Trade Summary & Expert Approved Momentum Ideas - Улправда
Why Xenetic Biosciences Inc. stock is in analyst buy zoneJuly 2025 Rallies & Stock Portfolio Risk Management - ulpravda.ru
Will Xenetic Biosciences Inc. stock attract more institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - Улправда
Is Xenetic Biosciences Inc. stock a safe haven assetJuly 2025 Opening Moves & Risk Managed Investment Strategies - Улправда
XBIO: No quorum was reached, so the meeting was adjourned and will be rescheduled - TradingView — Track All Markets
Trend Recap: Is Xenetic Biosciences Inc 3XB0 stock safe for risk averse investorsQuarterly Portfolio Summary & Weekly High Momentum Picks - Bộ Nội Vụ
Xenetic Biosciences, Inc.Common Stock (NQ: XBIO - FinancialContent
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Drop in Short Interest - Defense World
Is Xenetic Biosciences Inc. stock affected by interest rate hikesCash Flow Trends & Invest With Confidence - bollywoodhelpline.com
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Xenetic Biosciences, Inc. Share Price TodayLive NASDAQ: XBIO Stock Price Charts, History - Upstox
Financial Review: Xenetic Biosciences (NASDAQ:XBIO) & Talphera (NASDAQ:TLPH) - Defense World
Aug Gainers: Will Xenetic Biosciences Inc stock attract more institutional investorsTrend Reversal & High Accuracy Investment Entry Signals - moha.gov.vn
Why Xenetic Biosciences Inc. (3XB0) stock stays on buy listsProduct Launch & High Accuracy Investment Signals - Улправда
Is Xenetic Biosciences Inc. (3XB0) stock dividend growth reliableQuarterly Earnings Summary & Community Verified Swing Trade Signals - Улправда
Will Xenetic Biosciences Inc. stock outperform growth indexesPortfolio Return Report & Reliable Entry Point Alerts - DonanımHaber
Is Xenetic Biosciences Stock Built to Withstand More Downside? - Trefis
Published on: 2025-12-19 04:46:10 - Улправда
Is Xenetic Biosciences Inc. stock gaining market sharePortfolio Risk Report & Low Risk Entry Point Tips - Улправда
Published on: 2025-12-18 17:05:35 - Улправда
Contrasting Cosmos Health (NASDAQ:COSM) and Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences Earnings Notes - Trefis
Value Recap: Will Xenetic Biosciences Inc stock attract more institutional investorsMarket Performance Report & Verified Technical Signals - moha.gov.vn
Xenetic Biosciences Inc Stock (XBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):